Timothy J. Scannell joined the Synaptive Medical Board of Directors in August of 2022 as a Director.  He was elected Chair in June, 2023.  Mr. Scannell brings a wealth of experience in the medical device market having served in leadership positions with Stryker Corporation for over thirty years. At Stryker, he served as President and Chief Operating Officer from 2018 to 2021, and as group President of MedSurg and Neurotechnology from 2008 to 2018. Prior to these roles, he served as President of Stryker Spine, VP/GM of Stryker Biotech, and in a variety of sales and marketing leadership roles at Stryker Endoscopy.   

Mr. Scannell is a director of publicly held Insulet, Novocure, and Exact Sciences. Additionally, he is a director of privately held Regenity Biosciences and Cerebral Therapeutics.

Mr. Scannell holds a Bachelor of Business Administration and a Master of Business Administration from the University of Notre Dame.